Unlike earlier weight-management medicines, retatrutide is a triple receptor agonist , meaning it simultaneously targets three distinct hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
The decision depends on your bodys response, health goals, and cost considerations, and should always be made in collaboration with your doctor
Saccharomyces boulardii This strain is like a reset button for your stomach
This connection is often overlooked in discussions about metabolism during perimenopause and menopause
Weight trend: Review changes in context, not as a single number
Patients on this dose lost around 19 per cent of their body weight, still comparable to many currently approved obesity drugs, but experienced fewer side effects